Senseonics Gets FDA Approval for Eversense Implantable CGM System

Eversense Implantable CGM System
Senseonics, a company that develops implantable continuous glucose monitoring (CGM) system for people with diabetes, received FDA approval for the non-adjunctive indication (dosing claim) for its Eversense CGM. Related Nemaura’s […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleKenyan Invents Smart Gloves that Turn Sign Language Gestures into Audio Speech
Next articleCerna Home Care Releases “OnHand Assistance”, a Smartwatch for Seniors’ Safety
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)wearable-technologies.com.